Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy

Journal of Clinical Investigation

Volumn 115, Issue 2, 2005, Pages 237-246

  Angelillo Scherrer, Anne ^a,h   Burnier, Laurent ^a   Flores, Nathalie ^a   Savi, Pierre ^b   DeMol, Maria ^c   Schaeffer, Paul ^b   Herbert, Jean Marc ^b   Lemke, Greg ^d   Goff, Stephen P ^e   Matsushima, Glenn K ^f   Earp, H Shelton ^f   Vesin, Christian ^g   Hoylaerts, Marc F ^c   Plaisance, Stéphane ^c   Collen, Désiré ^c   Conway, Edward M ^c   Wehrle Haller, Bernhard ^g   Carmeliet, Peter ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SANOFI   (France)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^h University Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; BETA3 INTEGRIN; CALCIMYCIN; COLLAGEN; FIBRINOGEN; GROWTH ARREST SPECIFIC PROTEIN 6; PADGEM PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR; THROMBIN; TYROSINE; VON WILLEBRAND FACTOR; FIBRINOGEN RECEPTOR; GAS6 PROTEIN, MOUSE; GROWTH ARREST-SPECIFIC PROTEIN 6; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD CLOT RETRACTION; CONTROLLED STUDY; GENOTYPE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOSIS; THROMBUS; WESTERN BLOTTING; ANIMAL; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; INTEGRIN BETA3; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 85047694191     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22079     Document Type: Article

References (50)

1. Prevost, N., Woulfe, D., Tognolini, M., and Brass, L.F. 2003. Contact-dependent signaling during the late events of platelet activation. J. Thromb. Haemost. 1:1613-1627.
2. Law, D.A., et al. 1999. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature. 401:808-811.
3. Phillips, D.R., Prasad, K.S., Manganello J., Bao, M., and Nannizzi-Alaimo, L. 2001. Integrin tyrosine phosphorylation in platelet signaling. Curr. Opin. Cell Biol. 13:546-554.
4. Pasquer, J.M., Noury, M., and Nurden, A.T. 2002. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway. Thromb. Haemost. 88:115-122.
5. Prevosr, N., Woulfe, D., Tanaka, T., and Brass, L.F. 2002. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc. Natl. Acad. Sci. U. S. A. 99:9219-9224.
6. Prasad, K.S., et al. 2003. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc. Natl. Acad. Sci. U. S. A. 100:12367-12371.
7. Angelillo-Scherrer, A., et al. 2001. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat. Med. 7:215-221.
8. Nagata, K., et al. 1996. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J. Biol. Chem. 271:30022-30027.
9. Varnum, B.C., et al. 1995. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature. 373:623-626.
10. Sasaki, T., et al. 2002. Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domains. J. Biol. Chem. 277:44164-44170.
11. O'Bryan, J.P., et al. 1991. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol. 11:5016-5031.
12. Rescigno, J., Mansukhani, A., and Basilico, C. 1991. A putative receptor tyrosine kinase with unique structural topology. Oncogene. 6:1909-1913.
13. Lai, C., Gore, M., and Lemke, G. 1994. Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. Oncogene. 9:2567-2578.
14. Mark, M.R., et al. 1994. rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J. Biol. Chem. 269:10720-10728.
15. Graham, D.K., Dawson, T.L., Mullaney. D.L., Snodgrass, H.R., and Earp, H.S. 1994. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ. 5:647-657.
16. Mark, M.R., Chen, J., Hammonds, R.G., Sadick, M., and Godowsk, P.J. 1996. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J. Biol. Chem. 271:9785-9789.
17. Chen, J., Carey, K., and Godowski, P.J. 1997. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene. 14:2033-2039.
18. Goruppi, S., Ruaro, E., and Schneider, C. 1996. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 12:471-480.
19. Goruppi, S., Ruaro, E., Varnum, B., and Schneider, C. 1999. Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene. 18:4224-4236.
20. Demarchi, F., Verardo, R., Varnum, B., Brancolini, C., and Schneider, C. 2001. Gas6 anti-apoptotic signaling requires NF-kappa B activation. J. Biol. Chem. 276:31738-31744.
21. Lu, Q., et al. 1999. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 398:723-728.
22. Herbert, J.M., Bernar, A., and Maffrand, J.P. 1992. Importance of platelets in experimental venous thrombosis in the rat. Blood. 80:2281-2286.
23. Kawasaki, T., Dewerchin, M., Lijnen, H.R., Vermylen, J., and Hoylaerts, M.F. 2000. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Blood. 96:153-160.
24. Kawasaki, T., et al. 2001. Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ. Res. 88:159-166.
25. Piguet, P.F., et al. 1993. An effector role for platelers in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium. Infect. Immun. 61:4182-4187.
26. Sambrano, G.R., Weiss, E.J., Zheng, Y.W., Huang, W., and Coughlin, S.R. 2001. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature. 413:74-78.
27. Shattil, S.J., Kashiwagi, H., and Pampori, N. 1998. Integrin signaling: the platelet paradigm. Blood. 91:2645-2657.
28. Heiring, C., Dahlback, B., and Muller, Y.A. 2003. Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family. J. Biol. Chem. 279:6952-6958.
29. Payrastre, B., et al. 2000. The integrin alpha IIb/ beta 3 in human platelet signal transduction. Biochem. Pharmacol. 60:1069-1074.
30. DiMinno, G., and Silver, M.J. 1983. Mouse anti-thrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by erhyl alcohol. J. Pharmacol. Exp. Ther. 225:57-60.
31. Konishi, A., Aizawa, T., Mohan, A., Korshunov, V.A., and Berk, B.C. 2004. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J. Biol. Chem. 279:28766-28770.
32. Hall, M.O., Agnew, B.J., Abrams, T.A., and Burgess, B.L. 2003. The phagocytosis of os is mediated by the PI3-kinase linked tyrosine kinase receptor, mer, and is stimulated by GAS6. Adv. Exp. Med. Biol. 533:331-336.
33. Lu, Q., and Lemke, G. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 293:306-311.
34. Burgering, B.M., and Coffer, P.J. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599-602.
35. Kovacsovics, T.J., et al. 1995. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J. Biol. Chem. 270:11358-11366.
36. Trumel, C., et al. 1999. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood. 94:4156-4165.
37. Hodivala-Dilke, K.M., et al. 1999. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:229-238.
38. Smyth, S.S., Reis, E.D., Vaananen, H., Zhang, W., and Coller, B.S. 2001. Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood. 98:1055-1062.
39. Fabre, J.E., et al. 1999. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat. Med. 5:1199-1202.
40. Leon, C., et al. 1999. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest. 104:1731-1737.
41. Andre, P., et al. 2003. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J. Clin. Invest. 112:398-406.
42. Offermanns, S., Toombs, C.F., Hu, Y.H., and Simon, M.I. 1997. Defective platelet activation in G alpha(q)-deficient mice. Nature. 389:183-186.
43. Weiss, H.J., Hamilton, J.R., Lease, K.E., and Coughlin, S.K. 2002. Protection against thrombosis in mice lacking PAR3. Blood. 100:3240-3244.
44. Andre, P., et al. 2002. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat. Med. 8:247-252.
45. Munoz, X., et al. 2004. Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum. Mutat. 23:506-512.
46. Nurden, A.T. 1996. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors. Haemostasis. 26(Suppl. 4):78-88.
47. Grinnell, B.W., et al. 1990. Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood. 76:2546-2554.
48. Yan, S.B. 1996. Review of conformation-specific affinity purification methods for plasma vitamin K-dependent proteins. J. Mol. Recognit. 9:211-218.
49. Vogel, G.M., Meuleman, D.G., Bourgondien, F.G., and Hobbelen, P.M. 1989. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thromb. Res. 54:399-410.
50. Law, D.A., et al. 1999. Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets. Blood. 93:2645-2652.